Home
Company
- History and Mission
- Team
Technology & Products
Partners & Investors
News & Events
Menu

To search the site please enter a valid term

You are here: Home / Search results for ""

New Search

If you are not happy with the results below please do another search

Recent News

Second financing round secured for the development of COR-101 January 12, 2021
Human SARS-CoV-2 neutralizing antibody COR-101 demonstrates high efficacy in a COVID-19 animal model and is ready to be used in clinical studies to treat COVID-19 patients December 18, 2020
How human antibody COR-101 neutralizes the coronavirus SARS-CoV-2 December 4, 2020
CORAT won the Durchstarter Award of the State of Lower Saxony December 2, 2020
CORAT lead product COR-101 ready for clinical trials November 15, 2020
CORAT won the Innovation Award of the State of Lower Saxony September 28, 2020
Fighting SARS-CoV-2 with antibodies September 13, 2020
CORAT Therapeutics founded July 16, 2020
Fully neutralising antibodies to SARS-CoV-2 May 5, 2020
Visit by Lower Saxony’s health minister April 22, 2020
Minister Althusmann visits April 1, 2020

CONTACT

Contact

CORAT Therapeutics Gmbh

Inhoffenstr. 7
38124 Braunschweig,
Germany
Phone +49 1522 4047488

Commercial Registry: HRB 208500, Registergericht Braunschweig
V.i.S.d.P.: Dr. Andreas Herrmann

Followon Twitter

Pages

Home
Company
- History and Mission
- Team
Technology & Products
Partners & Investors
News & Events
Disclaimer

© Copyright - Corat Therapeutics - Enfold WordPress Theme by Kriesi

Home
Company
Technology & Products
Partners & Investors
News & Events